Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Adenine BP EP USP Pharma Grade stands out in the lineup of pharmaceutical raw materials as an essential building block for life and scientific progress. With the molecular formula C5H5N5 and a molecular weight of 135.13 g/mol, this compound shows up in pharmaceutical and biochemical laboratories around the world. Its structure, consisting of a purine ring system with distinct nitrogen atoms capable of hydrogen bonding, gives it powerful biochemical properties directly tied to DNA and RNA synthesis. This isn't just another powder in a jar—it's a high-purity substance, shaped to fit the strictest pharmacopoeial standards for use in critical medicine projects, vaccine development, and cell culture media.
Adenine often appears as white to yellowish, odorless solid, presenting in forms ranging from fine crystalline flakes to dry powders. The density measures 1.6 g/cm³, which informs handling and storage strategies in a busy laboratory setting. It doesn’t dissolve readily in cold water, but in hot or slightly acidic solutions, it opens up for easier mixing and preparation. In terms of appearance, it's dry, hard, and stable at room temperature. Because it comes in flake, powder, crystal, and pearl format, each form fits different handling methods and lab-scale needs. From my experience in research labs, the choice between powder and crystal usually boils down to solubility requirements and desired reaction rates. For example, the fine powder helps in rapid mixing, but crystals provide easier weighing without risk of loss as dust.
Global trade in pharmaceutical ingredients depends on clear labeling and traceability. Adenine falls under the HS Code 29335995, which covers other heterocyclic compounds with nitrogen hetero-atom(s) only. The product arrives as BP, EP, or USP grade, signifying that it aligns with British, European, and United States Pharmacopeia standards. That matters, because only with this certification can manufacturers and researchers ensure the right quality for regulatory compliance. The touch points for quality aren't just about purity—they involve testing for residual solvents, heavy metals, water content, and identification by IR spectroscopy. The main goal in manufacturing is to minimize contamination, safeguard batch-to-batch reproducibility, and ensure consistent results across applications, whether it be for medical injections, oral formulations, or laboratory assays.
Adenine doesn’t emit strong odors or vapor, but the solid should always be handled carefully. Though not especially volatile, the dust can cause mild irritation if inhaled or brought into contact with skin or eyes. Safety sheets list it as low hazard, but direct exposure invites risk, especially with large-scale handling. Laboratory staff opt for gloves and dust masks, and work within ventilated enclosures to keep accidental inhalation or ingestion at bay. On a larger scale, warehouse personnel pay attention to segregation from incompatible chemicals, such as strong acids and oxidizers, because accidental mixing generates unwanted reactions and can induce decomposition. Disposal follows regulations for non-hazardous chemical waste, but with the added attention to preventing material from entering drains or the environment uncontained.
Every major player in the pharmaceutical supply chain recognizes the critical nature of ultra-pure raw materials. Adenine, in its BP, EP, or USP grades, enters as a component to synthesize nucleotides, vital in mRNA vaccine development, antiviral research, and treatments targeting cellular metabolism. Biotech companies running cell culture systems depend on pharmaceutical-grade adenine for nutrient formulations that keep cultures alive and producing predictable, repeatable results. I’ve watched quality control teams reject entire batches when raw input purity slips, because downstream processes amplify any error. In creating pharmaceuticals, anything substandard can pass all the way to the patient, so skipping on grade simply doesn’t fly.
Supply chains in pharmaceuticals live and die on documentation and proper grade confirmation. Regulatory audits come as a routine part of doing business with adenine, and every batch must come with a certificate of analysis and supporting test data. Tracking the HS code supports cross-border compliance and helps enforce international standards. This complexity sometimes slows innovation, but it locks in patient safety. If more suppliers adopted routine third-party quality audits before shipping, global buyers could limit recalls, production halts, and lawsuits. Transparency through the whole chemical lifecycle—procurement, processing, application, and disposal—lets all parts of the chain trust their materials without always second-guessing the paperwork.
One way to reduce incident risk is through consistent operator training and clear handling protocols for all forms—powder, flakes, pearls, and crystals—especially in bulk-processing situations. Marking containers with both chemical and hazard identification symbols, combined with thorough access control to chemical areas, scales down opportunities for accidents. Investing in high-quality analytical equipment for in-house purity verification lessens dependence on external labs and supports tighter process controls. Manufacturing partners who invest in ISO certification, modern packaging that guards against moisture, and closed tracking systems build credibility fast in the pharma supply ecosystem. These efforts translate, over time, into fewer out-of-spec shipments, greater end-user trust, and ultimately safer, more effective treatments reaching the hands of medical professionals and patients.
Chengguan District, Lanzhou, Gansu, China
